Is Phentermine/Topiramate XR (Qsymia) in shortage in 2026? Here's the latest update on availability, cost, and what patients can do.
If you've been trying to fill a prescription for Phentermine/Topiramate XR (brand name Qsymia) and keep hitting dead ends, you're probably wondering: is there a shortage?
The short answer is no — Phentermine/Topiramate XR is not listed on the FDA Drug Shortages database as of early 2026. But that doesn't mean it's easy to find. The reality is more complicated than a simple yes or no, and understanding the details can help you get your medication faster.
Even though Qsymia isn't officially in shortage, many patients report difficulty finding it. Here's why it can feel that way:
Qsymia is only available through pharmacies certified under the Qsymia REMS program. This was put in place by the FDA because topiramate — one of the two active ingredients — can cause serious birth defects. The REMS means your regular pharmacy may simply not be allowed to dispense it.
This is the single biggest reason patients struggle to find Phentermine/Topiramate XR. It's not that the drug doesn't exist — it's that the number of pharmacies able to carry it is limited by design.
Phentermine/Topiramate XR is a Schedule IV controlled substance due to the phentermine component. Some pharmacies avoid stocking controlled substances that have limited demand, creating additional access barriers.
There is no generic version of Qsymia available in 2026. A single manufacturer (Vivus/Currax Pharmaceuticals) controls the supply. Without generic competition, production and distribution are concentrated rather than spread across multiple companies.
Interest in prescription weight management has surged, driven largely by the popularity of GLP-1 medications like Wegovy and Zepbound. As more patients and providers explore all available weight loss options, demand for Qsymia has increased as well — especially since it's an oral medication that doesn't require injections.
In a significant regulatory development, the FDA approved Phentermine/Topiramate XR (Qsymia) for pediatric chronic weight management in January 2026. The medication is now indicated for adolescents aged 12 and older with a BMI at or above the 95th percentile for their age and sex.
This is a major expansion of the drug’s approved use. Previously, Qsymia was only approved for adults. The pediatric approval was based on clinical trial data showing meaningful weight reduction in adolescents when combined with lifestyle modifications including diet and exercise.
For parents and caregivers, this means Qsymia is now a clinically validated, FDA-approved option for adolescent weight management — not an off-label use. However, the same REMS restrictions apply, and the medication must be prescribed by a healthcare provider experienced in pediatric weight management.
Important for adolescent patients: Topiramate can cause birth defects. Female patients of reproductive potential must have a negative pregnancy test before starting treatment and use effective contraception while taking Qsymia.
Cost is another major concern for patients. Here's what you can expect to pay:
Medicare Part D generally does not cover weight loss medications, including Qsymia. Some Medicaid plans do, depending on the state.
For a full breakdown of savings options, see our guide on how to save money on Phentermine/Topiramate XR.
The weight loss medication landscape is evolving rapidly. While Phentermine/Topiramate XR remains an effective option, patients now have more choices than ever:
For a detailed comparison, read our post on alternatives to Phentermine/Topiramate XR.
Here are the most effective steps you can take today:
Medfinder lets you search for pharmacies near you that have Phentermine/Topiramate XR in stock. It's the fastest way to avoid calling pharmacy after pharmacy.
The Qsymia Engage program ships Qsymia directly to your door for $98 per month. Visit QsymiaEngage.com or ask your prescriber to send your prescription to LifeLine Specialty Pharmacy.
Specialty and independent pharmacies are more likely to be REMS-certified. Call ahead and ask if they participate in the Qsymia REMS program.
Your prescriber's office may know which local pharmacies are certified and have stock. They can also send your prescription directly to a certified pharmacy or the home delivery option.
For more tips, see our complete guide on how to find Phentermine/Topiramate XR in stock near you.
Phentermine/Topiramate XR is not officially in shortage in 2026, but the REMS program, controlled substance status, and lack of a generic make it harder to find than most prescriptions. The key is knowing where to look: use Medfinder, explore the home delivery program, and work with your doctor to find the best path forward.
Your weight management journey shouldn't stall because of a pharmacy obstacle. With the right tools and information, you can get the medication you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
